These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20126673)

  • 1. Recent advances in the pharmacological treatment of cardiac arrythmias.
    Gramley F; Himmrich E; Mollnau H; Theis C; Hammwohner M; Goette A
    Drugs Today (Barc); 2009 Nov; 45(11):807-24. PubMed ID: 20126673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for atrial arrhythmias: present and future.
    Mazzini MJ; Monahan KM
    Heart Rhythm; 2008 Jun; 5(6 Suppl):S26-31. PubMed ID: 18456197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological modulation of gap junction function with the novel compound rotigaptide: a promising new principle for prevention of arrhythmias.
    Kjølbye AL; Haugan K; Hennan JK; Petersen JS
    Basic Clin Pharmacol Toxicol; 2007 Oct; 101(4):215-30. PubMed ID: 17845503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic properties of ranolazine--from bench to bedside.
    Tzeis S; Andrikopoulos G
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1733-41. PubMed ID: 22916846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating arrhythmias: an expert opinion.
    Dagres N; Sommer P; Anastasiou-Nana M; Hindricks G
    Expert Opin Pharmacother; 2011 Jun; 12(9):1359-67. PubMed ID: 21352091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranolazine: Electrophysiologic Effect, Efficacy, and Safety in Patients with Cardiac Arrhythmias.
    Shenasa M; Assadi H; Heidary S; Shenasa H
    Card Electrophysiol Clin; 2016 Jun; 8(2):467-79. PubMed ID: 27261835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dronedarone: an overview.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of atrial fibrillation: a pathophysiological perspective and review.
    Jacob S; Ali OA; Pidlaoan V; Badheka AO; Kerin NZ
    Am J Ther; 2011 May; 18(3):241-60. PubMed ID: 20861719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antiarrhythmic drugs for treatment of atrial fibrillation.
    Dobrev D; Nattel S
    Lancet; 2010 Apr; 375(9721):1212-23. PubMed ID: 20334907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac ion channels and mechanisms for protection against atrial fibrillation.
    Grunnet M; Bentzen BH; Sørensen US; Diness JG
    Rev Physiol Biochem Pharmacol; 2012; 162():1-58. PubMed ID: 21987061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel anti-arrhythmic agents for the treatment of atrial fibrillation.
    Wettwer E; Christ T; Dobrev D; Ravens U
    Curr Opin Pharmacol; 2007 Apr; 7(2):214-8. PubMed ID: 17303472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic therapy in atrial fibrillation.
    Ravens U
    Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New horizons in antiarrhythmic therapy: will novel agents overcome current deficits?
    Conway E; Musco S; Kowey PR
    Am J Cardiol; 2008 Sep; 102(6A):12H-19H. PubMed ID: 18790110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drugs vs. old concepts: a fresh look at antiarrhythmics.
    Thireau J; Pasquié JL; Martel E; Le Guennec JY; Richard S
    Pharmacol Ther; 2011 Nov; 132(2):125-45. PubMed ID: 21420430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmaceutical pipeline for atrial fibrillation.
    Santangeli P; Di Biase L; Pelargonio G; Burkhardt JD; Natale A
    Ann Med; 2011 Feb; 43(1):13-32. PubMed ID: 21166558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anthyarrhythmic drugs for atrial fibrillation.
    Matassini MV; Guerra F; Scappini L; Urbinati A; Capucci A
    Future Cardiol; 2015; 11(6):705-17. PubMed ID: 26631497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
    Das MK; Zipes DP
    J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiarrhythmic therapy--recent aspects of pharmacologic treatment].
    Patten M; Meinertz T
    Dtsch Med Wochenschr; 2005 May; 130(21):1325-9. PubMed ID: 15902621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological management of arrhythmias in the elderly.
    Van Gelder IC; Brügemann J; Crijns HJ
    Drugs Aging; 1997 Aug; 11(2):96-110. PubMed ID: 9259173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.